|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/00 | |
| A61K 31/428 | |||
| A61K 9/20 | |||
| A61K 9/08 | |||
| A61K 47/20 | |||
| A61K 47/26 | |||
| A61P 25/00 | |||
| A61P 25/16 | |||
| A61P 25/18 | |||
| A61P 25/22 | |||
| A61P 25/24 | |||
| A61P 25/28 | |||
| A61P 25/30 |
| (11) | Patento numeris | 3616686 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19186196.2 |
| Europos patento paraiškos padavimo data | 2015-11-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-03-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-05-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201462083094 P | 2014-11-21 | US |
| (72) |
CORIC, Vladimir, US
BERMAN, Robert, M., US
VLADYKA, Ronald, Samuel, US
SALEH, Amgad, US
YU, Danny, US
|
| (73) |
Biohaven Pharmaceutical Holding Company Ltd.,
234 Church Street Suite 301, New Haven, CT 06520,
US
|
| (54) | SUBLINGUAL FORMULATION OF RILUZOLE |
| SUBLINGUAL FORMULATION OF RILUZOLE |